In the current study, we applied this approach to characterize ACE status in patients with interstitial lung diseases and identified patients who have ACE in their blood originating not only from endothelial capillaries (mostly lung), as in healthy individuals, but also ACE from other sources (macrophages and dendritic cells of granulomas). Here, ACE is linked to interstitial lung disease.